A number of these studies have challenged canonical ideas of how GLP‐1 acts in the periphery and the brain to regulate eating behaviour, with important implications for the development of pharmacological treatments for obesity. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.